Search

everythinglearnresearchcommunity

for

Search:↓

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Silver nanoparticles may reduce chemotherapy side effects and improve cancer treatment.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Certain chemicals and drugs can cause hair loss.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

Some patients' hair grew back black and white after chemotherapy.

The cancer gene c-Myc increases harmful chemicals that damage DNA and can lead to cancer, but antioxidants can reduce this damage.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Combining standard treatment with exogenous cholinesterases can improve outcomes in severe organophosphate poisoning.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Mitotane changes steroid breakdown, affecting cortisol availability.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.